Publications by authors named "Priscilla Kinderman"

Claim this Profile
A
Alphavirus replicons encoding IFN-γ enhance cancer virotherapy by overcoming macrophage-mediated suppression.
Laura Horvathova, Priscilla Kinderman, Thijs Janzen, Baukje Nynke Hoogeboom, Franz J Weissing

iScience· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Naziia Kurmasheva, Aida Said, Boaz Wong, Priscilla Kinderman, Xiaoying Han

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.
Selas T F Bots, Tom J Harryvan, Christianne Groeneveldt, Priscilla Kinderman, Vera Kemp

Mol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Naziia Kurmasheva, Aida Said, Boaz Wong, Priscilla Kinderman, Xiaoying Han

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie

Cancer Immunol Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socs1-knockout in skin-resident CD4 T cells in a protracted contact-allergic reaction results in an autonomous skin inflammation with features of early-stage mycosis fungoides.
Yixin Luo, Maarten H Vermeer, Sanne de Haan, Priscilla Kinderman, Frank R de Gruijl

Biochem Biophys Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.
Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen

Cancer Res Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.
Christianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans, Camilla Labrie, Lisa Griffioen

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
Christianne Groeneveldt, Priscilla Kinderman, Diana J M van den Wollenberg, Ruben L van den Oever, Jim Middelburg

J Immunother Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.
Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, Melanie Lukkes, Larissa Klaase

J Immunother Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arming oncolytic reovirus with GM-CSF gene to enhance immunity.
Vera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, Thorbald van Hall, Priscilla Kinderman

Cancer Gene Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis